Markets

Insider Trading

Hedge Funds

Retirement

Opinion

AbbVie (ABBV) Benefitted from Top-Line Growth From Its Immunosuppressive Drugs

Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the same can be downloaded here. Global markets were in solidly positive territory for the third straight quarter of 2024 despite geopolitical volatility. Polaris Global Equity Composite (net of fees) returned 6.86% in the quarter, compared to 6.46% return for the MSCI World Index, gross dividends reinvested.  In addition, check the fund’s top five holdings to know its best picks in 2024.

Polaris Global Equity Strategy highlighted stocks like AbbVie Inc. (NYSE:ABBV)...